Stocks · Health care · Biological Products, (No Diagnostic Substances)

BIOCRYST PHARMACEUTICALS INC

BCRX Clue Score70

United States Fiscal year ends December CIK 0000882796 Results filed 4 Nov 2026

Add to watchlist

What the insiders did Mostly scheduled

By person

16 insiders · 14 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Alane P Barnes

Chief Legal Officer

—

$3.46M (7) scheduled

−$3.46M

400,703

0.1568%

$3.59M

+29.9%

Theresa Heggie

Director

—

$504.82K (1) scheduled

−$504.82K

80,646

0.0316%

$723.39K

+52.6%

Amy E McKee

Director

—

$100.28K (1)

−$100.28K

47,821

0.0187%

$428.95K

+71.8%

Machelle Sanders

Director

—

$68.54K (1) scheduled

−$68.54K

45,936

0.0180%

$412.05K

+65.6%

Jon P Stonehouse

Director

—

—

—

1,460,419

0.5715%

$13.10M

+20.5%

Charles K Gayer

President and CCO

—

—

—

952,583

0.3728%

$8.54M

+205.5%

Anthony Doyle

Chief Financial Officer

—

—

—

377,867

0.1479%

$3.39M

+41.2%

Helen M. Thackray

Chief R&D Officer

—

—

—

377,318

0.1477%

$3.38M

+38.6%

Babar Ghias

Chief Financial Officer

—

—

—

268,700

0.1052%

$2.41M

—

Sandeep Menon

Chief R&D Officer

—

—

—

205,150

0.0803%

$1.84M

—

Vincent Milano

Director

—

—

—

109,642

0.0429%

$983.49K

+45.5%

Nancy J Hutson

Director

—

—

—

99,138

0.0388%

$889.27K

+5.9%

Alan G Levin

Director

—

—

—

79,565

0.0311%

$713.70K

+53.7%

Steven Frank

Director

—

—

—

36,747

0.0144%

$329.62K

—

Jill C. Milne

Director

—

—

—

33,226

0.0130%

$298.04K

—

Steven K Galson

Director

—

—

—

27,794

0.0109%

$249.31K

—